-
1
-
-
84855314307
-
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
-
PID: 2204776
-
Clavien PA, Lesurtel M, Bossuyt PMM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11–22.
-
(2012)
Lancet Oncol.
, vol.13
, pp. 11-22
-
-
Clavien, P.A.1
Lesurtel, M.2
Bossuyt, P.M.M.3
Gores, G.J.4
Langer, B.5
Perrier, A.6
-
2
-
-
79951683605
-
Hepatocellular carcinoma: current management and perspectives for the future
-
PID: 2126331
-
Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011;253:453–69.
-
(2011)
Ann Surg.
, vol.253
, pp. 453-469
-
-
Rahbari, N.N.1
Mehrabi, A.2
Mollberg, N.M.3
-
3
-
-
80052301091
-
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?
-
PID: 2186595
-
Koniaris LG, Levi DM, Pedroso FE, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011;254:527–37.
-
(2011)
Ann Surg.
, vol.254
, pp. 527-537
-
-
Koniaris, L.G.1
Levi, D.M.2
Pedroso, F.E.3
-
4
-
-
58749114739
-
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables
-
PID: 1915332
-
Cescon M, Cucchetti A, Grazi GL, et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg. 2009;144:57–63.
-
(2009)
Arch Surg.
, vol.144
, pp. 57-63
-
-
Cescon, M.1
Cucchetti, A.2
Grazi, G.L.3
-
5
-
-
77955256950
-
The survival benefit of liver transplantation in hepatocellular carcinoma patients
-
PID: 2038143
-
Cillo U, Vitale A, Volk ML, et al. The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis. 2010;42:642–9.
-
(2010)
Dig Liver Dis.
, vol.42
, pp. 642-649
-
-
Cillo, U.1
Vitale, A.2
Volk, M.L.3
-
6
-
-
84858708400
-
National trends in surgical procedures for hepatocellular carcinoma: 1998–2008
-
PID: 2200938
-
Nathan H, Segev DL, Mayo SC, et al. National trends in surgical procedures for hepatocellular carcinoma: 1998–2008. Cancer. 2012;118:1838–44.
-
(2012)
Cancer.
, vol.118
, pp. 1838-1844
-
-
Nathan, H.1
Segev, D.L.2
Mayo, S.C.3
-
7
-
-
79952231921
-
American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update
-
PID: 2137466
-
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.
-
(2011)
Hepatology.
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
8
-
-
79959542936
-
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
-
PID: 2168421
-
Vitale A, Ramirez Morales R, Zanus G, et al. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol. 2011;12:654–62.
-
(2011)
Lancet Oncol.
, vol.12
, pp. 654-662
-
-
Vitale, A.1
Morales, R.R.2
Zanus, G.3
-
9
-
-
63449088149
-
Survival benefit–based deceased-donor liver allocation
-
COI: 1:STN:280:DC%2BD1M3lsFWgug%3D%3D, PID: 1934141
-
Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefit–based deceased-donor liver allocation. Am J Transplant. 2009;9:970–81.
-
(2009)
Am J Transplant.
, vol.9
, pp. 970-981
-
-
Schaubel, D.E.1
Guidinger, M.K.2
Biggins, S.W.3
-
10
-
-
57749191711
-
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
-
PID: 1905875
-
Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35–43.
-
(2009)
Lancet Oncol.
, vol.10
, pp. 35-43
-
-
Mazzaferro, V.1
Llovet, J.M.2
Miceli, R.3
-
11
-
-
84155178981
-
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis
-
PID: 2193238
-
Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132–40.
-
(2012)
Hepatology.
, vol.55
, pp. 132-140
-
-
Fuks, D.1
Dokmak, S.2
Paradis, V.3
Diouf, M.4
Durand, F.5
Belghiti, J.6
-
12
-
-
28844490547
-
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
-
PID: 1629801
-
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–31.
-
(2006)
J Hepatol.
, vol.44
, pp. 217-231
-
-
D’Amico, G.1
Garcia-Tsao, G.2
Pagliaro, L.3
-
13
-
-
84858658381
-
-
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43
-
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.
-
-
-
-
14
-
-
84873392306
-
Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions
-
COI: 1:CAS:528:DC%2BC3sXktFGqsQ%3D%3D, PID: 2339753
-
Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32:348–59.
-
(2012)
Semin Liver Dis.
, vol.32
, pp. 348-359
-
-
Bolondi, L.1
Burroughs, A.2
Dufour, J.F.3
-
15
-
-
0020445539
-
A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method
-
COI: 1:STN:280:DyaL3s%2FntFyluw%3D%3D, PID: 714888
-
Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method. Am J Med. 1982;73:883–8.
-
(1982)
Am J Med.
, vol.73
, pp. 883-888
-
-
Beck, J.R.1
Kassirer, J.P.2
Pauker, S.G.3
-
16
-
-
35148835537
-
Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA
-
PID: 1717333
-
O’Hagan A, Stevenson M, Madan J. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Econ. 2007;16:1009–23.
-
(2007)
Health Econ.
, vol.16
, pp. 1009-1023
-
-
O’Hagan, A.1
Stevenson, M.2
Madan, J.3
-
17
-
-
0025681857
-
Indexes and boundaries for “quantitative significance” in statistical decisions
-
COI: 1:STN:280:DyaK3M%2FntlWmsQ%3D%3D, PID: 225476
-
Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for “quantitative significance” in statistical decisions. J Clin Epidemiol. 1990;43:1273–84.
-
(1990)
J Clin Epidemiol.
, vol.43
, pp. 1273-1284
-
-
Burnand, B.1
Kernan, W.N.2
Feinstein, A.R.3
-
18
-
-
34547679626
-
Boosted regression trees with errors in variables
-
PID: 1768851
-
Sexton J, Laake P. Boosted regression trees with errors in variables. Biometrics. 2007;63:586–92.
-
(2007)
Biometrics.
, vol.63
, pp. 586-592
-
-
Sexton, J.1
Laake, P.2
-
19
-
-
84901231479
-
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit
-
Vitale A, Cucchetti A, Qiao GL, et al. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit. J Hepatol. 2014;60(6):1165-71
-
(2014)
J Hepatol
, vol.60
, Issue.6
, pp. 1165-1171
-
-
Vitale, A.1
Cucchetti, A.2
Qiao, G.L.3
-
20
-
-
84921026730
-
Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
-
Lim KC, Wang VW, Siddiqui FJ, et al. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. 2014 doi:10.1002/hep.27135
-
(2014)
Hepatology
-
-
Lim, K.C.1
Wang, V.W.2
Siddiqui, F.J.3
-
21
-
-
84857649294
-
Are patients with Child’s A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?
-
COI: 1:STN:280:DC%2BC383mvFajtg%3D%3D, PID: 2212343
-
Berry K, Ioannou GN. Are patients with Child’s A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation? Am J Transplant. 2012;12:706–17.
-
(2012)
Am J Transplant.
, vol.12
, pp. 706-717
-
-
Berry, K.1
Ioannou, G.N.2
-
22
-
-
70350020415
-
Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score
-
PID: 1975685
-
Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg. 2009;33:2412–9.
-
(2009)
World J Surg.
, vol.33
, pp. 2412-2419
-
-
Hsu, K.Y.1
Chau, G.Y.2
Lui, W.Y.3
Tsay, S.H.4
King, K.L.5
Wu, C.W.6
-
23
-
-
71149083124
-
Perioperative risk assessment for hepatocellular carcinoma by using the MELD score
-
PID: 1966246
-
Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg. 2009;13:2268–75.
-
(2009)
J Gastrointest Surg.
, vol.13
, pp. 2268-2275
-
-
Delis, S.G.1
Bakoyiannis, A.2
Dervenis, C.3
Tassopoulos, N.4
-
24
-
-
25144483939
-
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
-
PID: 1612395
-
Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–92.
-
(2005)
Liver Transpl.
, vol.11
, pp. 1086-1092
-
-
Pawlik, T.M.1
Delman, K.A.2
Vauthey, J.N.3
-
25
-
-
44649111962
-
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
-
PID: 1854987
-
Ishizawa TI, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.
-
(2008)
Gastroenterology.
, vol.134
, pp. 1908-1916
-
-
Ishizawa, T.I.1
Hasegawa, K.2
Aoki, T.3
|